BRCA Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of BRCA Antibodies for research focused on understanding BRCA1 and BRCA2 in cellular processes. BRCA Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BRCA1 and BRCA2 maintain genomic stability and are integral to DNA repair mechanisms. Mutations in BRCA genes significantly increase the risk of breast and ovarian cancers, highlighting their importance in cancer research and therapeutic development. Research focusing on BRCA1 and BRCA2 continues to reveal new insights about their roles in DNA damage response pathways. Understanding BRCA gene expression patterns helps identify potential therapeutic targets for cancer treatment. Ongoing studies of BRCA1 and BRCA2 contribute to developing more effective cancer prevention strategies. Current research explores how BRCA mutations affect cellular responses to various cancer treatments. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of BRCA proteins and their impact on cancer biology.